These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 20001763)

  • 41. Insulin analogues in pregnancy and specific congenital anomalies: a literature review.
    de Jong J; Garne E; Wender-Ozegowska E; Morgan M; de Jong-van den Berg LT; Wang H
    Diabetes Metab Res Rev; 2016 May; 32(4):366-75. PubMed ID: 26431249
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pan-insulin allergy and severe lipoatrophy complicating Type 2 diabetes.
    Tavare AN; Doolittle HJ; Baburaj R
    Diabet Med; 2011 Apr; 28(4):500-3. PubMed ID: 21392071
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment with the long-acting insulin analogues detemir or glargine during pregnancy in women with type 1 diabetes: comparison of glycaemic control and pregnancy outcome.
    Callesen NF; Damm J; Mathiesen JM; Ringholm L; Damm P; Mathiesen ER
    J Matern Fetal Neonatal Med; 2013 Apr; 26(6):588-92. PubMed ID: 23211128
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The impact of insulin glargine on clinical and humanistic outcomes in patients uncontrolled on other insulin and oral agents: an office-based naturalistic study.
    Fischer JS; McLaughlin T; Loza L; Beauchamp R; Schwartz S; Kipnes M
    Curr Med Res Opin; 2004 Nov; 20(11):1703-10. PubMed ID: 15537471
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early hypoglycaemia after accidental intramuscular injection of insulin glargine.
    Karges B; Boehm BO; Karges W
    Diabet Med; 2005 Oct; 22(10):1444-5. PubMed ID: 16176210
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A severe case of lipoatrophy due to human insulin and insulin analogs in a patient with diabetes: is an immunological mechanism involved?
    Cabrera-Freitag P; Escalada J; Goikoetxea MJ; Laguna S; Sanz ML; Gastaminza G
    J Investig Allergol Clin Immunol; 2011; 21(5):417-9. PubMed ID: 21905513
    [No Abstract]   [Full Text] [Related]  

  • 47. The role of new basal insulin analogues in the initiation and optimisation of insulin therapy in type 2 diabetes.
    Baxter MA
    Acta Diabetol; 2008 Dec; 45(4):253-68. PubMed ID: 18766296
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Insulin therapy in pregnancy complicated by diabetes: are insulin analogs a new tool?
    Lapolla A; Dalfrà MG; Fedele D
    Diabetes Metab Res Rev; 2005; 21(3):241-52. PubMed ID: 15818714
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Insulin-induced lipoatrophy: evidence for an immune pathogenesis.
    Reeves WG; Allen BR; Tattersall RB
    Br Med J; 1980 Jun; 280(6230):1500-3. PubMed ID: 6992934
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intermediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir.
    Peterson GE
    Curr Med Res Opin; 2006 Dec; 22(12):2613-9. PubMed ID: 17166343
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Basal insulins: Pharmacological properties and patient perspectives.
    Abrahamson MJ
    Prim Care Diabetes; 2010 Apr; 4 Suppl 1():S19-23. PubMed ID: 20394887
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Distant site lipoatrophy: a rare complication of subcutaneous insulin therapy.
    Chakraborty PP; Biswas SN
    Postgrad Med J; 2016 Jan; 92(1083):57-8. PubMed ID: 26561591
    [No Abstract]   [Full Text] [Related]  

  • 53. Human recombinant DNA insulin-induced lipoatrophy in a patient with type 2 diabetes mellitus.
    Mu L; Goldman JM
    Endocr Pract; 2000; 6(2):151-2. PubMed ID: 11421532
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Insulin-induced localized lipoatrophy preceded by shingles (herpes zoster): a case report.
    Chantelau EA; Prätor R; Prätor J
    J Med Case Rep; 2014 Jun; 8():223. PubMed ID: 24961832
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lipoatrophy and monocomponent porcine insulin.
    Jones GR; Statham B; Owens DR; Jones MK; Hayes TM
    Br Med J (Clin Res Ed); 1981 Jan; 282(6259):190. PubMed ID: 6779945
    [No Abstract]   [Full Text] [Related]  

  • 56. Lipoatrophic diabetes: a case report with a brief review of the literature.
    Lawson MA
    J Adolesc Health; 2009 Jan; 44(1):94-5. PubMed ID: 19101466
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lipoatrophy in a girl with type 1 diabetes: beneficial effects of treatment with a glucocorticoid added to an insulin analog.
    Swelheim HT; Westerlaken C; van Pinxteren-Nagler E; Bocca G
    Diabetes Care; 2012 Mar; 35(3):e22. PubMed ID: 22355025
    [No Abstract]   [Full Text] [Related]  

  • 58. Lipoatrophy in children, adolescents and adults with insulin pump treatment: Is there a beneficial effect of insulin glulisine?
    Kordonouri O; Biester T; Weidemann J; Ott H; Remus K; Grothaus J; Pisarek N; Hartmann R; Adolph K; Lange K; Danne T
    Pediatr Diabetes; 2020 Nov; 21(7):1285-1291. PubMed ID: 32738019
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Insulin injection lipoatrophy recidivus.
    Rosenbloom AL
    Pediatr Diabetes; 2014 Feb; 15(1):73-4. PubMed ID: 23763651
    [No Abstract]   [Full Text] [Related]  

  • 60. Cross-reactivity of insulin analogues with three insulin assays.
    Dayaldasani A; Rodríguez Espinosa M; Ocón Sánchez P; Pérez Valero V
    Ann Clin Biochem; 2015 May; 52(Pt 3):312-8. PubMed ID: 25172526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.